Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 1
2014 7
2015 4
2016 3
2017 4
2018 4
2019 9
2020 3
2021 5
2022 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges.
Seijo LM, Peled N, Ajona D, Boeri M, Field JK, Sozzi G, Pio R, Zulueta JJ, Spira A, Massion PP, Mazzone PJ, Montuenga LM. Seijo LM, et al. Among authors: boeri m. J Thorac Oncol. 2019 Mar;14(3):343-357. doi: 10.1016/j.jtho.2018.11.023. Epub 2018 Dec 4. J Thorac Oncol. 2019. PMID: 30529598 Free PMC article. Review.
Potential biomarkers for lung cancer screening.
Sozzi G, Boeri M. Sozzi G, et al. Among authors: boeri m. Transl Lung Cancer Res. 2014 Jun;3(3):139-48. doi: 10.3978/j.issn.2218-6751.2014.06.04. Transl Lung Cancer Res. 2014. PMID: 25806293 Free PMC article. Review.
Exo-miRNAs as a New Tool for Liquid Biopsy in Lung Cancer.
Fortunato O, Gasparini P, Boeri M, Sozzi G. Fortunato O, et al. Among authors: boeri m. Cancers (Basel). 2019 Jun 25;11(6):888. doi: 10.3390/cancers11060888. Cancers (Basel). 2019. PMID: 31242686 Free PMC article. Review.
Cytisine Therapy Improved Smoking Cessation in the Randomized Screening and Multiple Intervention on Lung Epidemics Lung Cancer Screening Trial.
Pastorino U, Ladisa V, Trussardo S, Sabia F, Rolli L, Valsecchi C, Ledda RE, Milanese G, Suatoni P, Boeri M, Sozzi G, Marchianò A, Munarini E, Boffi R, Gallus S, Apolone G. Pastorino U, et al. Among authors: boeri m. J Thorac Oncol. 2022 Nov;17(11):1276-1286. doi: 10.1016/j.jtho.2022.07.007. Epub 2022 Jul 28. J Thorac Oncol. 2022. PMID: 35908731 Free article. Clinical Trial.
Therapeutic use of microRNAs in lung cancer.
Fortunato O, Boeri M, Verri C, Moro M, Sozzi G. Fortunato O, et al. Among authors: boeri m. Biomed Res Int. 2014;2014:756975. doi: 10.1155/2014/756975. Epub 2014 Sep 16. Biomed Res Int. 2014. PMID: 25309923 Free PMC article. Review.
MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT Pathway.
Moro M, Fortunato O, Bertolini G, Mensah M, Borzi C, Centonze G, Andriani F, Di Paolo D, Perri P, Ponzoni M, Pastorino U, Sozzi G, Boeri M. Moro M, et al. Among authors: boeri m. Pharmaceuticals (Basel). 2022 Feb 28;15(3):297. doi: 10.3390/ph15030297. Pharmaceuticals (Basel). 2022. PMID: 35337095 Free PMC article.
Prognostic determinants in epithelioid sarcoma.
Gasparini P, Facchinetti F, Boeri M, Lorenzetto E, Livio A, Gronchi A, Ferrari A, Massimino M, Spreafico F, Giangaspero F, Forni M, Maestro R, Alaggio R, Pilotti S, Collini P, Modena P, Sozzi G. Gasparini P, et al. Among authors: boeri m. Eur J Cancer. 2011 Jan;47(2):287-95. doi: 10.1016/j.ejca.2010.09.003. Eur J Cancer. 2011. PMID: 20932739
46 results